Eosinophilia in patients infected with the human immunodeficiency virus
The prevalence and significance of peripheral blood eosinophilia in patients infected with the human immunodeficiency virus (HIV) were evaluated. Fifteen of 119 consecutive patients had absolute eosinophil counts of > 450/mm3. During a mean follow-up period of 419 days eosinophilia could be ident...
Gespeichert in:
| Veröffentlicht in: | European journal of clinical microbiology & infectious diseases 1997-09, Vol.16 (9), p.675-677 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 677 |
|---|---|
| container_issue | 9 |
| container_start_page | 675 |
| container_title | European journal of clinical microbiology & infectious diseases |
| container_volume | 16 |
| creator | TIETZ, A SPONAGEL, L ERB, P BUCHER, H BATTEGAY, M ZIMMERLI, W |
| description | The prevalence and significance of peripheral blood eosinophilia in patients infected with the human immunodeficiency virus (HIV) were evaluated. Fifteen of 119 consecutive patients had absolute eosinophil counts of > 450/mm3. During a mean follow-up period of 419 days eosinophilia could be identified as secondary to a parasitic infection in only one patient. Correlation with disease stage showed a higher rate of advanced disease in patients with absolute eosinophilia. In a multivariate regression analysis, only low CD4+ cell counts, not the CDC disease stage or the use of antiretroviral therapy or primary prophylaxis, contributed significantly to the prevalence of eosinophilia. It is concluded that expensive laboratory investigations in asymptomatic patients with advanced-stage HIV disease are neither necessary nor cost effective. |
| doi_str_mv | 10.1007/BF01708558 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79372384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16236009</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-4d58eea7595df2e7e27d46fafc75f03c60e61a29a12928fbfbcb9132bb639d63</originalsourceid><addsrcrecordid>eNqF0UtLAzEQB_AgSq3Vi3dhEfEgrOaxeR21tFUoeOl9yWYTNmUfNdlV-u2NdKngxdMMzI-BmT8A1wg-Igj508sSIg4FpeIETFFGaJoRTk7BFEqSpZJjcg4uQtjCiAXnEzCRhGLM0BSsFl1wbberXO1U4tpkp3pn2j7E3hrdmzL5cn2V9JVJqqFRbeKaZmi70linI9T75NP5IVyCM6vqYK7GOgOb5WIzf03X76u3-fM61RmkfZqVVBijOJW0tNhwg3mZMaus5tRCohk0DCksFcISC1vYQhcSEVwUjMiSkRm4P6zd-e5jMKHPGxe0qWvVmm4IOZckXiuyfyFimDAY_zMDt3_gtht8G2_IGcKCQUxwRA8HpH0Xgjc233nXKL_PEcx_Ish_I4j4Ztw4FI0pj3T8eZzfjXMVtKqtV6124ciwwBwLSb4BeuWM_g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>612860232</pqid></control><display><type>article</type><title>Eosinophilia in patients infected with the human immunodeficiency virus</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>TIETZ, A ; SPONAGEL, L ; ERB, P ; BUCHER, H ; BATTEGAY, M ; ZIMMERLI, W</creator><creatorcontrib>TIETZ, A ; SPONAGEL, L ; ERB, P ; BUCHER, H ; BATTEGAY, M ; ZIMMERLI, W</creatorcontrib><description>The prevalence and significance of peripheral blood eosinophilia in patients infected with the human immunodeficiency virus (HIV) were evaluated. Fifteen of 119 consecutive patients had absolute eosinophil counts of > 450/mm3. During a mean follow-up period of 419 days eosinophilia could be identified as secondary to a parasitic infection in only one patient. Correlation with disease stage showed a higher rate of advanced disease in patients with absolute eosinophilia. In a multivariate regression analysis, only low CD4+ cell counts, not the CDC disease stage or the use of antiretroviral therapy or primary prophylaxis, contributed significantly to the prevalence of eosinophilia. It is concluded that expensive laboratory investigations in asymptomatic patients with advanced-stage HIV disease are neither necessary nor cost effective.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/BF01708558</identifier><identifier>PMID: 9352261</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Adult ; AIDS/HIV ; Antiretroviral agents ; Biological and medical sciences ; CD4 Lymphocyte Count ; Eosinophilia - complications ; Eosinophilia - epidemiology ; Female ; Hematologic Diseases - physiopathology ; HIV ; HIV Infections - complications ; HIV Infections - epidemiology ; Human immunodeficiency virus ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Male ; Medical diagnosis ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Prophylaxis ; Regression analysis</subject><ispartof>European journal of clinical microbiology & infectious diseases, 1997-09, Vol.16 (9), p.675-677</ispartof><rights>1997 INIST-CNRS</rights><rights>MMV Medizin Verlag GmbH 1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-4d58eea7595df2e7e27d46fafc75f03c60e61a29a12928fbfbcb9132bb639d63</citedby><cites>FETCH-LOGICAL-c405t-4d58eea7595df2e7e27d46fafc75f03c60e61a29a12928fbfbcb9132bb639d63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2827289$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9352261$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TIETZ, A</creatorcontrib><creatorcontrib>SPONAGEL, L</creatorcontrib><creatorcontrib>ERB, P</creatorcontrib><creatorcontrib>BUCHER, H</creatorcontrib><creatorcontrib>BATTEGAY, M</creatorcontrib><creatorcontrib>ZIMMERLI, W</creatorcontrib><title>Eosinophilia in patients infected with the human immunodeficiency virus</title><title>European journal of clinical microbiology & infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>The prevalence and significance of peripheral blood eosinophilia in patients infected with the human immunodeficiency virus (HIV) were evaluated. Fifteen of 119 consecutive patients had absolute eosinophil counts of > 450/mm3. During a mean follow-up period of 419 days eosinophilia could be identified as secondary to a parasitic infection in only one patient. Correlation with disease stage showed a higher rate of advanced disease in patients with absolute eosinophilia. In a multivariate regression analysis, only low CD4+ cell counts, not the CDC disease stage or the use of antiretroviral therapy or primary prophylaxis, contributed significantly to the prevalence of eosinophilia. It is concluded that expensive laboratory investigations in asymptomatic patients with advanced-stage HIV disease are neither necessary nor cost effective.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Antiretroviral agents</subject><subject>Biological and medical sciences</subject><subject>CD4 Lymphocyte Count</subject><subject>Eosinophilia - complications</subject><subject>Eosinophilia - epidemiology</subject><subject>Female</subject><subject>Hematologic Diseases - physiopathology</subject><subject>HIV</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - epidemiology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Prophylaxis</subject><subject>Regression analysis</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqF0UtLAzEQB_AgSq3Vi3dhEfEgrOaxeR21tFUoeOl9yWYTNmUfNdlV-u2NdKngxdMMzI-BmT8A1wg-Igj508sSIg4FpeIETFFGaJoRTk7BFEqSpZJjcg4uQtjCiAXnEzCRhGLM0BSsFl1wbberXO1U4tpkp3pn2j7E3hrdmzL5cn2V9JVJqqFRbeKaZmi70linI9T75NP5IVyCM6vqYK7GOgOb5WIzf03X76u3-fM61RmkfZqVVBijOJW0tNhwg3mZMaus5tRCohk0DCksFcISC1vYQhcSEVwUjMiSkRm4P6zd-e5jMKHPGxe0qWvVmm4IOZckXiuyfyFimDAY_zMDt3_gtht8G2_IGcKCQUxwRA8HpH0Xgjc233nXKL_PEcx_Ish_I4j4Ztw4FI0pj3T8eZzfjXMVtKqtV6124ciwwBwLSb4BeuWM_g</recordid><startdate>19970901</startdate><enddate>19970901</enddate><creator>TIETZ, A</creator><creator>SPONAGEL, L</creator><creator>ERB, P</creator><creator>BUCHER, H</creator><creator>BATTEGAY, M</creator><creator>ZIMMERLI, W</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>19970901</creationdate><title>Eosinophilia in patients infected with the human immunodeficiency virus</title><author>TIETZ, A ; SPONAGEL, L ; ERB, P ; BUCHER, H ; BATTEGAY, M ; ZIMMERLI, W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-4d58eea7595df2e7e27d46fafc75f03c60e61a29a12928fbfbcb9132bb639d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Antiretroviral agents</topic><topic>Biological and medical sciences</topic><topic>CD4 Lymphocyte Count</topic><topic>Eosinophilia - complications</topic><topic>Eosinophilia - epidemiology</topic><topic>Female</topic><topic>Hematologic Diseases - physiopathology</topic><topic>HIV</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - epidemiology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Prophylaxis</topic><topic>Regression analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TIETZ, A</creatorcontrib><creatorcontrib>SPONAGEL, L</creatorcontrib><creatorcontrib>ERB, P</creatorcontrib><creatorcontrib>BUCHER, H</creatorcontrib><creatorcontrib>BATTEGAY, M</creatorcontrib><creatorcontrib>ZIMMERLI, W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical microbiology & infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TIETZ, A</au><au>SPONAGEL, L</au><au>ERB, P</au><au>BUCHER, H</au><au>BATTEGAY, M</au><au>ZIMMERLI, W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eosinophilia in patients infected with the human immunodeficiency virus</atitle><jtitle>European journal of clinical microbiology & infectious diseases</jtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>1997-09-01</date><risdate>1997</risdate><volume>16</volume><issue>9</issue><spage>675</spage><epage>677</epage><pages>675-677</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>The prevalence and significance of peripheral blood eosinophilia in patients infected with the human immunodeficiency virus (HIV) were evaluated. Fifteen of 119 consecutive patients had absolute eosinophil counts of > 450/mm3. During a mean follow-up period of 419 days eosinophilia could be identified as secondary to a parasitic infection in only one patient. Correlation with disease stage showed a higher rate of advanced disease in patients with absolute eosinophilia. In a multivariate regression analysis, only low CD4+ cell counts, not the CDC disease stage or the use of antiretroviral therapy or primary prophylaxis, contributed significantly to the prevalence of eosinophilia. It is concluded that expensive laboratory investigations in asymptomatic patients with advanced-stage HIV disease are neither necessary nor cost effective.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>9352261</pmid><doi>10.1007/BF01708558</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0934-9723 |
| ispartof | European journal of clinical microbiology & infectious diseases, 1997-09, Vol.16 (9), p.675-677 |
| issn | 0934-9723 1435-4373 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79372384 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Adult AIDS/HIV Antiretroviral agents Biological and medical sciences CD4 Lymphocyte Count Eosinophilia - complications Eosinophilia - epidemiology Female Hematologic Diseases - physiopathology HIV HIV Infections - complications HIV Infections - epidemiology Human immunodeficiency virus Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Male Medical diagnosis Medical sciences Middle Aged Multivariate Analysis Prophylaxis Regression analysis |
| title | Eosinophilia in patients infected with the human immunodeficiency virus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T12%3A31%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eosinophilia%20in%20patients%20infected%20with%20the%20human%20immunodeficiency%20virus&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=TIETZ,%20A&rft.date=1997-09-01&rft.volume=16&rft.issue=9&rft.spage=675&rft.epage=677&rft.pages=675-677&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/BF01708558&rft_dat=%3Cproquest_cross%3E16236009%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=612860232&rft_id=info:pmid/9352261&rfr_iscdi=true |